Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
Background: For patients with symptomatic intracranial artery stenosis (sICAS), endovascular treatment has been shown to be feasible and safe in recent studies. However, in-stent restenosis (ISR) risks the recurrence of ischemic stroke. We attempt to elucidate the risk factors for ISR.Methods: We re...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2020.601199/full |
_version_ | 1818725739858493440 |
---|---|
author | Xu Guo Ning Ma Feng Gao Da-Peng Mo Gang Luo Zhong-Rong Miao |
author_facet | Xu Guo Ning Ma Feng Gao Da-Peng Mo Gang Luo Zhong-Rong Miao |
author_sort | Xu Guo |
collection | DOAJ |
description | Background: For patients with symptomatic intracranial artery stenosis (sICAS), endovascular treatment has been shown to be feasible and safe in recent studies. However, in-stent restenosis (ISR) risks the recurrence of ischemic stroke. We attempt to elucidate the risk factors for ISR.Methods: We retrospectively analyzed 97 patients with sICAS from a prospective registry trial that included 20 centers from September 2013 to January 2015. Cases were classified into the ISR≥ 50% group or the ISR < 50% group. The baseline characteristics and long-term follow-up were compared between the two groups. Binary logistic regression analyses were identified as an association between ISR and endovascular technique factors.Results: According to whether ISR was detected by CT angiography, 97 patients were divided into the ISR group (n = 24) and the non-ISR group (n = 73). The admission baseline features and lesion angiography characteristics were similar, while plasma hs-CRP (mg/L) was higher in the ISR≥ 50% group at admission (8.2 ± 11.4 vs. 2.8 ± 4.1, p = 0.032). Binary logistic regression analysis identified the longer stents (adjusted OR 0.816, 95% CI 0.699–0.953; p = 0.010), balloon-mounted stents (adjusted OR 5.748, 95% CI 1.533–21.546; p = 0.009), and local anesthesia (adjusted OR 6.000, 95% CI 1.693–21.262; p = 0.006) as predictors of ISR at the 1-year follow-up.Conclusions: The longer stents, balloon-mounted stents implanted in the intracranial vertebral or basilar artery, and local anesthesia were significantly associated with in-stent restenosis. Further studies are required to identify accurate biomarkers or image markers associated with ISR in ICAS patients.Clinical Trial Registration:www.ClinicalTrials.gov, identifier: NCT01968122. |
first_indexed | 2024-12-17T21:47:06Z |
format | Article |
id | doaj.art-95b0d2a00b6541918ff27778dfd2dbb8 |
institution | Directory Open Access Journal |
issn | 1664-2295 |
language | English |
last_indexed | 2024-12-17T21:47:06Z |
publishDate | 2021-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Neurology |
spelling | doaj.art-95b0d2a00b6541918ff27778dfd2dbb82022-12-21T21:31:26ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-01-011110.3389/fneur.2020.601199601199Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in ChinaXu GuoNing MaFeng GaoDa-Peng MoGang LuoZhong-Rong MiaoBackground: For patients with symptomatic intracranial artery stenosis (sICAS), endovascular treatment has been shown to be feasible and safe in recent studies. However, in-stent restenosis (ISR) risks the recurrence of ischemic stroke. We attempt to elucidate the risk factors for ISR.Methods: We retrospectively analyzed 97 patients with sICAS from a prospective registry trial that included 20 centers from September 2013 to January 2015. Cases were classified into the ISR≥ 50% group or the ISR < 50% group. The baseline characteristics and long-term follow-up were compared between the two groups. Binary logistic regression analyses were identified as an association between ISR and endovascular technique factors.Results: According to whether ISR was detected by CT angiography, 97 patients were divided into the ISR group (n = 24) and the non-ISR group (n = 73). The admission baseline features and lesion angiography characteristics were similar, while plasma hs-CRP (mg/L) was higher in the ISR≥ 50% group at admission (8.2 ± 11.4 vs. 2.8 ± 4.1, p = 0.032). Binary logistic regression analysis identified the longer stents (adjusted OR 0.816, 95% CI 0.699–0.953; p = 0.010), balloon-mounted stents (adjusted OR 5.748, 95% CI 1.533–21.546; p = 0.009), and local anesthesia (adjusted OR 6.000, 95% CI 1.693–21.262; p = 0.006) as predictors of ISR at the 1-year follow-up.Conclusions: The longer stents, balloon-mounted stents implanted in the intracranial vertebral or basilar artery, and local anesthesia were significantly associated with in-stent restenosis. Further studies are required to identify accurate biomarkers or image markers associated with ISR in ICAS patients.Clinical Trial Registration:www.ClinicalTrials.gov, identifier: NCT01968122.https://www.frontiersin.org/articles/10.3389/fneur.2020.601199/fullcerebrovascular diseasestrokeendovascular treatmentinterventional neurologyintracranial in-stent restenosis |
spellingShingle | Xu Guo Ning Ma Feng Gao Da-Peng Mo Gang Luo Zhong-Rong Miao Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China Frontiers in Neurology cerebrovascular disease stroke endovascular treatment interventional neurology intracranial in-stent restenosis |
title | Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China |
title_full | Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China |
title_fullStr | Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China |
title_full_unstemmed | Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China |
title_short | Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China |
title_sort | long term risk factors for intracranial in stent restenosis from a multicenter trial of stenting for symptomatic intracranial artery stenosis registry in china |
topic | cerebrovascular disease stroke endovascular treatment interventional neurology intracranial in-stent restenosis |
url | https://www.frontiersin.org/articles/10.3389/fneur.2020.601199/full |
work_keys_str_mv | AT xuguo longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina AT ningma longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina AT fenggao longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina AT dapengmo longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina AT gangluo longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina AT zhongrongmiao longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina |